We are live on
!
Find out more
Avalo Therapeutics
AVTX
AVTX
19.62
USD
+0.62
3.26%
At close
Updated
Sep 4, 11:29 AM EDT
Pre-market
After hours
1 day
3.26%
5 days
1.13%
1 month
5.88%
3 months
44.16%
6 months
6.86%
Year to date
15.28%
1 year
93.11%
5 years
-99.76%
10 years
-99.83%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
MAM
1
MPM Asset Management
Boston,
Massachusetts
| $2M | +$2.27M | +207 | New |
|
| 2 |
NMC
2
NEA Management Company
Timonium,
Maryland
| $1.2M | +$2.27M | +207 | New |
|
| 3 |
BCCM
3
Blue Clay Capital Management
Minneapolis,
Minnesota
| $140K | +$164K | +15 | New |
|
| 4 |
4
Citadel Advisors
Miami,
Florida
| $19K | +$21.9K | +2 | New |
|
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
| 6 |
6
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|